middle.news
Vitrafy and U.S. Army Complete Phase II Platelet Cryopreservation Study with Promising No-Wash Protocol Results
8:34am on Wednesday 8th of April, 2026 AEST
•
Healthcare
Read Story
Vitrafy and U.S. Army Complete Phase II Platelet Cryopreservation Study with Promising No-Wash Protocol Results
8:34am on Wednesday 8th of April, 2026 AEST
Key Points
Phase II study expanded sample size to over 60 platelet samples
Wash-based protocol results consistent with Phase I benchmarks
No-wash protocol showed comparable or improved outcomes
Final report and analysis expected in Q4 FY2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE